D.C. Mun. Regs. tit. 22-B, § 1500
1500.1 In carrying out its functions under the Act, the Chief Pharmaceutical Control Officer and his or her designee, is authorized in accordance with §§302(f) and 505 of the Act to enter controlled premises and conduct administrative and non-administrative inspections thereof, for the purpose of doing the following:
1500.2 If an administrative inspection warrant is required for inspection pursuant to §505 of the Act (D.C. Code, 2001 Ed. §48-905.05), the Chief shall be responsible for seeking the warrant.
1500.3 The Chief may, without a warrant, inspect books and records pursuant to an administrative subpoena issued in accordance with §507 of the Act (D.C. Code, 2001 Ed. §48-905.07) and in situations described in §505(a)(4) of the Act D.C. Code, 2001 Ed. §48-905.05(a)(4).
1500.4 An inspection authorized by this section shall not extend to financial data, sales data, other than shipment data, or pricing data unless the owner, operator, or agent in charge of the controlled premises consents in writing.
1500.5 Refusal by the registrant or owner, operator, agent or other person in charge of the controlled premises to allow an inspection shall constitute a basis for suspension or revocation of registration in the following circumstances:
(a) When inspection is authorized pursuant to an administrative inspection warrant issued pursuant to §505(b) of the Act (D.C. Code, 2001 Ed. §48-905.05(b)); and
(b) When inspection is authorized pursuant to this chapter and §505(a)(4)(B), (C), (D) or (E) of the Act (D.C. Code, 2001 Ed. §48-905.05(a)(4) (B), (C), (D) or (E)).
AUTHORITY: Unless otherwise noted, the authority for this chapter is Title III of the District of Columbia Uniform Controlled Substances Act of 1981, D.C. Code, 2001 Ed. §§48-903.01 to 48-903.09; Mayor's Order 85-171 (October 18, 1985).
SOURCE: Final Rulemaking published at 33 DCR 1046, 1077 (February 21, 1986).